RPB Study Urges Glaucoma Screening for Older African Americans

Routine screening of older African Americans for glaucoma -- a high-risk group -- would significantly reduce the incidence of blindness at relatively low cost, RPB researchers report in a recently published study. According to the report,... Read more...

 

Gene Therapy for Inherited Blindness Takes Another Step Forward

Researchers further improved vision in three adult patients previously treated in one eye. After receiving the same treatment in their other eye, the patients became better able to see in dim light, and two were able to navigate obstacles... Read more...

 

Potential New Treatment Target for Retinoblastoma

RPB researchers have identified the mechanism that causes a rare and aggressive cancer that can be fatal if diagnosed at an advanced stage.  What's more, experimental drugs already in clinical trials for adults with leukemia and... Read more...

 

RPB Chair, David F. Weeks, Steps Down After 50 Years

Diane S. Swift to become Chair at Research to Prevent Blindness David F. Weeks stepped down as Chairman and CEO of Research to Prevent Blindness (RPB) at the end of 2011, after having served the organization for 50 years as of September 1.... Read more...

 

Revolutionary Scanner Detects "Lazy Eye" in Children With High Degree of Accuracy

RPB researchers have developed and tested a simple, seconds-long screening exam with a handheld scanning device to enable pediatricians to identify amblyopia, the leading cause of... Read more...

 

Dry AMD Breakthrough

Researchers, led by RPB-supported Dr. Jayakrishna Ambati, have discovered a molecular mechanism implicated in geographic atrophy, the major cause of untreatable blindness in the industrialized world. They have also developed two promising... Read more...

 

New Hope In Fight Against AMD

A gene therapy approach using a protein called CD59, or protectin, shows promise in slowing the signs of age-related macular degeneration (AMD), according to a new in vivo study by RPB-supported researchers at Tufts University School... Read more...

 

50 Years of Research to Prevent Blindness

Since it was founded in 1960, RPB has been a catalyst in vision research, responsible for spawning a vibrant community of eye research institutions, for initiating the movement that led to the creation of the National Eye Institute, for... Read more...

 

Breakthrough Gene Therapy Prevents Retinal Degeneration

RPB-supported researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts have demonstrated that non-viral gene therapy, delivered by nanoparticles, can delay the onset of some forms... Read more...

 

Healthy Diet May Reduce Cataracts in Women

Women who eat foods rich in a variety of vitamins and minerals appear to have a lower risk of developing cataracts, according to a large population study. Read the press release. Read the article. Read the abstract. Read more...